BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence. Cells 2019;8:E376. [PMID: 31027278 DOI: 10.3390/cells8040376] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Toon K, Bentley EM, Mattiuzzo G. More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation. Viruses 2021;13:217. [PMID: 33572589 DOI: 10.3390/v13020217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Luo L, Liang W, Pang J, Xu G, Chen Y, Guo X, Wang X, Zhao Y, Lai Y, Liu Y, Li B, Su B, Zhang S, Baniyash M, Shen L, Chen L, Ling Y, Wang Y, Liang Q, Lu H, Zhang Z, Wang F. Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals. Cell Discov 2021;7:89. [PMID: 34580278 DOI: 10.1038/s41421-021-00321-x] [Reference Citation Analysis]
3 [DOI: 10.1063/1.5127485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Datfar T, Doulberis M, Papaefthymiou A, Hines IN, Manzini G. Viral Hepatitis and Hepatocellular Carcinoma: State of the Art. Pathogens 2021;10:1366. [PMID: 34832522 DOI: 10.3390/pathogens10111366] [Reference Citation Analysis]
5 Santiago AM, da Silva Graça Amoras E, Queiroz MAF, da Silva Conde SRS, Cayres-Vallinoto IMV, Ishak R, Vallinoto ACR. TNFA -308G>A and IL10 -1082A>G polymorphisms seem to be predictive biomarkers of chronic HCV infection. BMC Infect Dis 2021;21:1133. [PMID: 34732154 DOI: 10.1186/s12879-021-06835-9] [Reference Citation Analysis]
6 Kupke P, Werner JM. Hepatitis E Virus Infection-Immune Responses to an Underestimated Global Threat. Cells 2021;10:2281. [PMID: 34571931 DOI: 10.3390/cells10092281] [Reference Citation Analysis]
7 Cohen JM, Kridin K, Perez-Chada LM, Merola JF, Cohen AD. Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study. Int J Dermatol 2021. [PMID: 33998670 DOI: 10.1111/ijd.15578] [Reference Citation Analysis]
8 Holub M, Stráníková A, Beran O, Arientová S, Bartoš O, Kondelková K, Plíšek S, Chalupa P. Chronic Hepatitis C Virus Infection Modulates the Transcriptional Profiles of CD4+ T Cells. Can J Infect Dis Med Microbiol 2021;2021:6689834. [PMID: 33777278 DOI: 10.1155/2021/6689834] [Reference Citation Analysis]
9 Li Q, An N, Yin X, Zhang R, Shao H, Yi D, Cen S. MxB Disrupts Hepatitis C Virus NS5A–CypA Complex: Insights From a Combined Theoretical and Experimental Approach. Front Microbiol 2022;13:849084. [DOI: 10.3389/fmicb.2022.849084] [Reference Citation Analysis]
10 Sekulic S, Mijailovic Z, Petrovic D, Lukic R, Jovanovic M, Jovanovic I. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021;0:000010247820210010. [DOI: 10.2478/sjecr-2021-0010] [Reference Citation Analysis]
11 Bokelmann M, Vogel U, Debeljak F, Düx A, Riesle-Sbarbaro S, Lander A, Wahlbrink A, Kromarek N, Neil S, Couacy-Hymann E, Prescott J, Kurth A. Tolerance and Persistence of Ebola Virus in Primary Cells from Mops condylurus, a Potential Ebola Virus Reservoir. Viruses 2021;13:2186. [PMID: 34834992 DOI: 10.3390/v13112186] [Reference Citation Analysis]
12 Echeverría N, Comas V, Aldunate F, Perbolianachis P, Moreno P, Cristina J. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World J Hepatol 2021; 13(10): 1234-1268 [PMID: 34786164 DOI: 10.4254/wjh.v13.i10.1234] [Reference Citation Analysis]
13 Duncan JD, Urbanowicz RA, Tarr AW, Ball JK. Hepatitis C Virus Vaccine: Challenges and Prospects. Vaccines (Basel) 2020;8:E90. [PMID: 32079254 DOI: 10.3390/vaccines8010090] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
14 Fiorino S, Gallo C, Zippi M, Sabbatani S, Manfredi R, Moretti R, Fogacci E, Maggioli C, Travasoni Loffredo F, Giampieri E, Corazza I, Dickmans C, Denitto C, Cammarosano M, Battilana M, Orlandi PE, Del Forno F, Miceli F, Visani M, Acquaviva G, De Leo A, Leandri P, Hong W, Brand T, Tallini G, Jovine E, Jovine R, de Biase D. Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy. Aging Clin Exp Res 2020;32:2115-31. [PMID: 32865757 DOI: 10.1007/s40520-020-01669-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
15 Aslam S, Yumul I, Mariski M, Pretorius V, Adler E. Outcomes of heart transplantation from hepatitis C virus–positive donors. The Journal of Heart and Lung Transplantation 2019;38:1259-67. [DOI: 10.1016/j.healun.2019.08.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
16 Al‐saffar OB, Ad'hiah AH. Genetic variants in IL4RA , IL6 , and IL12B genes and susceptibility to hepatitis B and C virus infections among Iraqi patients. J Med Virol 2020;92:3448-58. [DOI: 10.1002/jmv.26297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ho E, Van Hees S, Goethals S, Smits E, Huizing M, Francque S, De Winter B, Michielsen P, Vanwolleghem T. Biobanking for Viral Hepatitis Research. Front Med (Lausanne) 2019;6:183. [PMID: 31482092 DOI: 10.3389/fmed.2019.00183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Spencer Clinton JL, Tran LL, Vogt MB, Rowley DR, Kimata JT, Rico-Hesse R. IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells. PLoS One 2020;15:e0244587. [PMID: 33378361 DOI: 10.1371/journal.pone.0244587] [Reference Citation Analysis]
19 Farcomeni S, Moretti S, Fimiani C, Sulekova LF, Vescio F, Sernicola L, Maggiorella MT, Remoli AL, Picconi O, Mosca L, Esvan R, Biliotti E, Ciccozzi M, Sgarbanti M, Taliani G, Borsetti A. Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy. Pathogens 2021;10:1488. [PMID: 34832642 DOI: 10.3390/pathogens10111488] [Reference Citation Analysis]
20 Sokolova TM. [Hepatitis C virus (Flaviviridae: Hepacivirus: Hepacivirus C): regulation of signaling reactions of innate immunity]. Vopr Virusol 2021;65:307-16. [PMID: 33533227 DOI: 10.36233/0507-4088-2020-65-6-1] [Reference Citation Analysis]
21 Tang B, Zhu G, Chen C, Zheng S, Pu Y, Xu Y, Huang H, Wang G, Huang D, Liu Y, Zhang X. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma. Laryngoscope 2021;131:1774-81. [PMID: 33592124 DOI: 10.1002/lary.29422] [Reference Citation Analysis]
22 Qian X, Wu B, Xu C, Qi Z. Hepatitis C Virus Infection Cycle-Specific MicroRNA Profiling Reveals Stage-Specific miR-4423-3p Targets RIG-I to Facilitate Infection. Front Cell Infect Microbiol 2022;12:851917. [DOI: 10.3389/fcimb.2022.851917] [Reference Citation Analysis]
23 Zeng H, Li L, Hou Z, Zhang Y, Tang Z, Liu S. Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges. Int J Med Sci. 2020;17:892-902. [PMID: 32308542 DOI: 10.7150/ijms.43079] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
24 Kardani K, Sadat SM, Kardani M, Bolhassani A. The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Rev Vaccines 2021;20:839-55. [PMID: 34114513 DOI: 10.1080/14760584.2021.1941895] [Reference Citation Analysis]
25 Essa S, Al-Attiyah R, Siddique I, Al-Nakib W. Modulation of Immune Cell Subsets by Hepatitis C Virus and Antiviral Therapy in Early Virological Response HCV Genotype 4-Infected Patients with Compensated Liver Disease. Med Princ Pract 2021;30:168-77. [PMID: 32966988 DOI: 10.1159/000511783] [Reference Citation Analysis]
26 Abouelasrar Salama S, Lavie M, De Buck M, Van Damme J, Struyf S. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection. Cytokine Growth Factor Rev 2019;50:29-42. [PMID: 31718982 DOI: 10.1016/j.cytogfr.2019.10.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
27 Liang J, Wu M, Bai C, Ma C, Fang P, Hou W, Wei X, Zhang Q, Du Y. Network Pharmacology Approach to Explore the Potential Mechanisms of Jieduan-Niwan Formula Treating Acute-on-Chronic Liver Failure. Evid Based Complement Alternat Med 2020;2020:1041307. [PMID: 33456481 DOI: 10.1155/2020/1041307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Soliman SHA, Orlacchio A, Verginelli F. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis. Microorganisms 2021;9:1179. [PMID: 34070716 DOI: 10.3390/microorganisms9061179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wróblewska A, Bielawski KP, Sikorska K. Occult Infection with Hepatitis C Virus: Looking for Clear-Cut Boundaries and Methodological Consensus. JCM 2021;10:5874. [DOI: 10.3390/jcm10245874] [Reference Citation Analysis]
30 Khatun M, Zhang J, Ray R, Ray RB. Hepatitis C Virus Evades Interferon Signaling by Suppressing Long Noncoding RNA Linc-Pint Involving C/EBP-β. J Virol 2021;95:e0095221. [PMID: 34160260 DOI: 10.1128/JVI.00952-21] [Reference Citation Analysis]
31 Reyentovich A, Gidea CG, Smith D, Lonze B, Kon Z, Fargnoli A, Pavone J, Rao S, Saraon T, Lewis T, Qian Y, Jacobson I, Moazami N. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors. Clin Transplant 2020;34. [DOI: 10.1111/ctr.13989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Sepulveda-Crespo D, Resino S, Martinez I. Hepatitis C virus vaccine design: focus on the humoral immune response. J Biomed Sci 2020;27:78. [PMID: 32631318 DOI: 10.1186/s12929-020-00669-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Orr C, Masur H, Kottilil S, Meissner EG. Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8+ T-Cell Function. Open Forum Infect Dis 2021;8:ofab118. [PMID: 33959672 DOI: 10.1093/ofid/ofab118] [Reference Citation Analysis]
34 Yang J, Zhong M, Hong K, Yang Q, Zhang E, Zhou D, Xia J, Chen YQ, Sun M, Zhao B, Xiang J, Liu Y, Han Y, Xu M, Zhou X, Huang C, Shang Y, Yan H. Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study. Clin Transl Immunology 2021;10:e1259. [PMID: 33728049 DOI: 10.1002/cti2.1259] [Reference Citation Analysis]
35 Zhou R, Liu L, Wang Y. Viral proteins recognized by different TLRs. J Med Virol 2021;93:6116-23. [PMID: 34375002 DOI: 10.1002/jmv.27265] [Reference Citation Analysis]
36 Balgoma D, Gil-de-Gómez L, Montero O. Lipidomics Issues on Human Positive ssRNA Virus Infection: An Update. Metabolites 2020;10:E356. [PMID: 32878290 DOI: 10.3390/metabo10090356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Li J, Boix E. Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses. Virulence 2021;12:444-69. [PMID: 33660566 DOI: 10.1080/21505594.2021.1871823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Cifaldi L, Doria M, Cotugno N, Zicari S, Cancrini C, Palma P, Rossi P. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection? Int J Mol Sci 2019;20:E3715. [PMID: 31366013 DOI: 10.3390/ijms20153715] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
39 Cai H, Liu G, Zhong J, Zheng K, Xiao H, Li C, Song X, Li Y, Xu C, Wu H, He Z, Zhu Q. Immune Checkpoints in Viral Infections. Viruses 2020;12:E1051. [PMID: 32967229 DOI: 10.3390/v12091051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
40 Saraceni C, Birk J. A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis. J Clin Transl Hepatol 2021;9:409-18. [PMID: 34221927 DOI: 10.14218/JCTH.2020.00095] [Reference Citation Analysis]
41 Meng Z, Liu Q, Sun F, Qiao L. Hepatitis C virus nonstructural protein 5A perturbs lipid metabolism by modulating AMPK/SREBP-1c signaling. Lipids Health Dis 2019;18:191. [PMID: 31684957 DOI: 10.1186/s12944-019-1136-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]